GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Price-to-Operating-Cash-Flow

Curatis Holding AG (XSWX:CURN) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Price-to-Operating-Cash-Flow?

As of today (2025-06-03), Curatis Holding AG's share price is CHF12.20. Curatis Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-1.20. Hence, Curatis Holding AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Curatis Holding AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

XSWX:CURN's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.54
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Curatis Holding AG's Cash Flow from Operations per share for the six months ended in Jun. 2024 was CHF-0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-1.20.

Curatis Holding AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Curatis Holding AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Price-to-Operating-Cash-Flow Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Curatis Holding AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Price-to-Operating-Cash-Flow falls into.


;
;

Curatis Holding AG Price-to-Operating-Cash-Flow Calculation

Curatis Holding AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=12.20/-1.204
=

Curatis Holding AG's Share Price of today is CHF12.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Curatis Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-1.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Curatis Holding AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
CURNz:UK 26U:Germany
Address
Weierweg 7, Liestal, CHE, CH-4410
Website
https://www.curatis.com
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.